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Abstract
Background—Cancer registration data is vital for creating evidence-based policies and 
interventions. Quantifying the resources needed for cancer registration activities and identifying 
potential efficiencies are critically important to ensure sustainability of cancer registry operations.
Methods—Using a previously validated web-based cost assessment tool, we collected activity-
based cost data and report findings using 3 years of data from 40 National Program of Cancer 
Registry grantees. We stratified registries by volume: low-volume included fewer than 10,000 
cases, medium-volume included 10,000–50,000 cases, and high-volume included >50,000 cases.
Results—Low-volume cancer registries incurred an average of $93.11 to report a case (without 
in-kind contributions) compared with $27.70 incurred by high-volume registries. Across all 
registries, the highest cost per case was incurred for data collection and abstraction ($8.33), 
management ($6.86), and administration ($4.99). Low- and medium-volume registries have higher 
costs than high-volume registries for all key activities.
Conclusions—Some cost differences by volume can be explained by the large fixed costs 
required for administering and performing registration activities, but other reasons may include the 
quality of the data initially submitted to the registries from reporting sources such as hospitals and 
pathology laboratories. Automation or efficiency improvements in data collection can potentially 
reduce overall costs.
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1. Background
Annually, more than 1.4 million people in the United States are diagnosed with cancer, and 
these cancer cases are recorded by cancer registries (U.S. Cancer Statistics Working Group, 
2013). Cancer registries play a critical role in providing the information needed to develop 
comprehensive and targeted cancer control interventions to reduce the burden of cancer. 
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Information about cancer incidence is needed to evaluate cancer trends; identify and address 
cancer disparities; and track progress toward cancer prevention and control goals, such as 
those established by Healthy People 2020 (U.S. Department of Health and Human Services, 
2014).
In 1992, the U.S. Congress passed the Cancer Registries Amendment Act, which authorized 
the Centers for Disease Control and Prevention (CDC) to establish the National Program of 
Cancer Registries (NPCR) and provide financial support and technical assistance to state 
health departments for the operation of central population-based cancer registries to collect 
complete, timely, and high quality data on cancer incidence. Currently, the NPCR supports 
cancer registries in 45 states, the District of Columbia, Puerto Rico, and the Pacific Island 
jurisdictions (Centers for Disease Control and Prevention, 2015). The NPCR and the 
Surveillance, Epidemiology and End Results (SEER) Program provide support to cancer 
registries in all 50 states, covering the entire United States population (National Cancer 
Institute, 2015). In addition to the federal initiatives, states also provide significant matching 
funds to support the operations of cancer registries.
Although some prior studies have reported on the cost of cancer registry operations, there 
has been no systematic assessment of the cost expended on specific activities performed by 
the registries. A previous study estimated the average cost per case reported by NPCR-
funded registries and identified factors that explained state variations (Weir, Berg, Mansley, 
& Belloni, 2005). However, that study underestimated the true cost (with a median cost per 
case of $18.43 and range from $3 to $230), as state funding and in-kind contributions were 
not included. Other studies have reported activity-based costs collected from a small number 
of cancer registries (median cost per case of $45.84 ranging from $30 to $100) though their 
findings cannot be generalized to the overall U.S. population (Tangka, Subramanian, Cole 
Beebe, Trebino, & Michaud, 2010; Subramanian, Tangka, Green, Weir, & Michaud, 2009). 
Identifying the resources required for cancer registration activities and increasing 
efficiencies is critically important to ensure optimal use of the funding available from 
federal, state, and in-kind contributions.
The objective of the current study was to estimate the average cost per single cancer case for 
each key registration activity performed by NPCR-funded registries using more 
representative data and more complete data than prior studies. Central cancer registries 
perform a large number of core surveillance (key activities related to collection of cancer 
incidence data and maintenance of the registry database [Appendix Table A1]), data 
enhancement, and analysis activities. Previous analyses have observed potential economies 
of scale in registration operations or noted that further research is needed to understand 
variations in cost per case across registries (Weir et al., 2005; Tangka et al., 2010). In this 
study, we stratify registries based on volume to explore the cost per case incurred in each 
group for specific registration activities. Our findings may help to quantify the resources 
needed for cancer registration activities, lead to understanding of variations in cost per case 
for specific activities, and identify approaches that can improve the efficiency of registry 
operations.
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2. Methods
We used a previously developed web-based Cost Assessment Tool (web-CAT) to collect 
activity-based cost data from the 48 NPCR-funded registries. The NPCR web-CAT was 
developed using economic evaluation theory and activity-based costing methodology 
(Anderson, Bowland, Cartwright, & Bassin, 1998; Drummond, Sculpher, Torrance, O’Brien, 
& Stoddart, 2005; French, Dunlap, Zarkin, McGeary, & McLellan, 1997; Salome, French, 
Miller, & McLellan, 2003). Details on the web-CAT development and validation have been 
previously reported (Subramanian et al., 2007; Subramanian, Ekwueme, Gardner, Bapat, & 
Kramer, 2008). The web-CAT allows for data collection across budget categories, including 
labor, consultant and contract expenditures, computer software and hardware, travel and 
training, and administrative or overhead expenses. The NPCR web-CAT includes 10 screens 
that collect data on various aspects of registry operations: (1) descriptive details on the 
registry itself, including program type; (2) total expenditures (all funding sources); (3) in-
kind contributions; (4) personnel expenditures; (5) personnel activities; (6) consultant/
contractor expenditures; (7) computers, travel, training and other expenditures; (8) software 
expenditures and details on the database management software used by the registry; (9) 
administrative costs; and (10) factors affecting registry operations (including number of 
cases reported, records received, data submission formats). In addition, a final screen 
provided a summary of the data reported by the registry and a confirmation screen allowed 
the user to submit the data. In addition to introductory information with background on the 
economic evaluation of the NPCR and general instructions on entering, saving, and 
submitting data, the user’s guide also provided detailed information and instruction for each 
web-CAT screen.
Registry staff members (often the registry director) were asked to allocate expenditures 
(including employee time) to various program activities. The cost data was reported 
retrospectively and registry staff allocated actual expenditure to specific activities. To ensure 
that data was standardized across the registries, we offered training webinars, a detailed 
user’s guide with definitions for each activity, and ongoing technical assistance to address 
any questions about data collection and reporting. The percent time reported was provided 
by the registry staff and then multiplied by the annual salary (or actually time spent if it is 
less than 12 months). The cost for each activity was summed up.
Cost data were collected for a 3-year period (program years 2008–2009, 2009–2010, 2010–
2011) on registry funding (including in-kind contributions), expenditures, number of cases 
reported, and factors that might affect the efficiency of operating a central cancer registry. 
We collected cost data for multiple years to account for variations in registry activities and 
costs from year to year. In addition, because cases are collected and processed on a continual 
basis (takes up to two years to collect complete data on a case), we used the number of cases 
reported during the cost data collection period to calculate the cost per case. This is based on 
methodology previously used and since cases do not vary dramatically between years, the 
number reported provide a good approximation of the cases at various stages of completion 
in any given funding period (Subramanian et al., 2009). Given the two year delay in 
reporting cancer cases, we used cancer cases diagnosed in 2006, 2007 and 2008 for the 
program years 2008–2009, 2009–2010, 2010–2011 respectively. In addition, to standardize 
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calculations for cost per case, we limited the cases used in the analysis to in-state cases 
collected by the registry.
We used a programmatic perspective, taking into account all resources, regardless of 
funding source, in our activity-based cost assessment. In-kind contributions included 
nonmonetary assistance and support provided to the registries. In-kind labor contributions 
include physician consultation to the registry, IT services, and time spent by state 
administrator to support registry activities while in-kind non-labor contributions include 
supplies and materials, and office space. Registries reported in-kind contributions directly 
and also provided the method used for estimating the value of each contribution. Reported 
methods include internal best estimates, market value, and foundation budget amounts 
(when resources were allocated to provide goods/services to the cancer registry).
We performed a series of data checks to ensure the accuracy of the data reported by 
registries. Several of these data checks were automated within the web-CAT (for example, 
totals of each allocation category sum to 100% and funds expended match expenditure 
allocated for the fiscal year), which ensured that final submission met key data quality 
standards. We limited the difference between reported funding and total expenditures 
allocated to specific activities to within a difference of 5%. We also required reported time 
spent on activities to total 100% for each registry employee. In cases where a registry used a 
major contractor, both the registry and the contractor were required to submit data via the 
web-CAT. To facilitate the aggregation of registry and contractor data and to avoid double 
counting, reported funding for both the contractor and registry were linked.
Finally, we further validated the data by comparing reported NPCR funding in the web-CAT 
with funding amounts in CDC records. Each registry-reported number of cancer cases was 
compared with CDC internal records and United States Cancer Statistics (USCS) cancer 
cases; these served as guidelines for assessing accuracy, as cases were not expected to match 
exactly (registries may report additional cases not required by CDC or USCS). Registries 
reviewed and approved summaries of the validated data following each of the three rounds 
of data collection.
To create activity-based cost data files, we first allocated costs to specific registry activities 
by totaling the cost of each registry activity across all budget categories. For example, in 
terms of personnel costs, the percent time reported by the registry staff was multiplied by the 
annual salary (or actually time spent if it is less than 12 months) and then the cost for each 
activity was summed up. Next, we added together expenditures that did not have any 
associated registry activity and prorated those across all registry activities. We adjusted cost 
per case for regional cost of living using the Employment Cost Index (U.S. Bureau of Labor 
Statistics, 2014).
Overall, seven NPCR-funded registries also receive cases collected through the SEER 
Program. To avoid misinterpreting any unmeasured differences between these registries and 
the other NPCR registries, we excluded these observations from the analysis. In addition, we 
also excluded the Pacific Regional Central Cancer Registry as this registry was not yet fully 
operational during the data collection period.
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We stratified the 40 remaining registries by volume based on natural breaks and outliers 
present in the data; low-volume included those with fewer than 10,000 cases, medium-
volume were those with 10,000–50,000 cases, and high-volume were those with more than 
50,000 cases. The mean number of cases reported among low-volume registries was 5738 
(with a standard deviation of 2433). Medium-volume registries had a mean of 26,232 
(10,343) cases reported. High-volume registries had a mean of 92,642 (19,415) cases 
reported.
We noted the key characteristics of the registries including program type (health department, 
contractor, or private organization), geographic region, size of area served (using U.S. 
Census data, we classified geographic areas as small [less than 42,000 square miles], 
medium [42,000–69,000 square miles], or large [more than 69,000 square miles]), software 
used, and consolidation effort (number of cases reported versus number of records received). 
We also examined the certification status of each registry with the North American 
Association of Central Cancer Registrars (NAACCR) to assess the quality of the data 
submitted. NAACCR certifies registries annually for the most recent year of incidence data 
reported, to identify registries that have complete and accurate data for computing cancer 
incidence statistics (NAACCR, 2015). Finally, we logged the portion of cases from 
reporting sources that passed automatic edits (indicating high quality data) and whether a 
significant portion of the records were received via electronic submissions.
Using volume stratification, we present a detailed assessment of funding, in-kind 
contributions, and cost per case, both overall and by registry activity. The average cost and 
the 95% confidence interval are reported as appropriate. We ran multivariate tests of means 
(Wilks’ lambda, Pillai’s trace, Lawley-Hotelling trace, Roy’s largest root) to compare the 
registry characteristics and the means of the cost per case variables for each of the three 
volume categories: low, medium, and high. Means that were significantly different (10% or 
better) across the groups are identified in the table and text.
3. Results
Table 1 presents the registry characteristics overall and stratified by volume categories. The 
majority of the registries were part of health departments, and few used contractors or were 
run by private organizations. Of the 40 registries included in our analyses, 17.5% were 
located in the Northeast, 37.5% were located in the South, 25.0% were in the Midwest, and 
20.0% were in the West. While medium-volume registries were fairly evenly distributed 
among small, medium, and large areas served, low-volume registries served very few (7.7%) 
medium-sized areas (F = 6.77). High-volume registries tend to use internally developed 
tools at a significantly higher rate than low- or medium-volume registries (F = 3.80). The 
consolidation effort varied across registries but this difference was not statistically 
significant. Medium and larger registries were more likely to have achieved NAACCR gold 
standards (more than 80% compared with about 70%) and there were a significantly larger 
proportion of low volume registries who achieved silver status. High-volume registries had 
significantly larger proportions of records that were reported electronically (F = 2.95) and 
also had significantly higher percentages of records that passed 100% of the edits at the time 
of data submission (F = 2.73).
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Table 2 reports the funding amount and sources of the funding. The average amounts 
(standard deviations in parentheses) of annual funding for low-, medium-, and high-volume 
registries were $482,198 ($138,706), $1,051,410 ($417,145) and $2,858,425 ($1,695,795), 
respectively. Multivariate tests of means indicate these estimates were significantly different 
across the volume categories (F = 24.04). On average, the NPCR was the largest source of 
funding for the low- and medium-volume registries (F = 26.25) while on average nonfederal 
sources (generally states) provided the most funding for high-volume registries (F = 14.90). 
Total in-kind contributions increased with the size of registries from an average of $163,793 
($132.219) among low-volume registries to $828,380 ($1295,043) and $1014,821 
($1967,004) among medium- and high-volume registries respectively, though the 
differences in means across volume categories was not statistically significant.
Table 3 presents the cost per case of core and enhanced activities for each reporting period 
and averaged across the 3 years. Most of the registry funds, more than 90%, were spent on 
core registry activities (such as registry management, case ascertainment, and quality 
assurance activities) while only a small portion of funds, about 7%, was allocated to 
enhanced registry activities (such as implementing cancer inquiry response systems, 
performing research studies, and publishing research study results). The average cost per 
case for core registry activities (F = 12.26) was $93.11, $42.10, and $27.70 for low-, 
medium-, and high-volume registries, respectively, while the distribution of enhanced 
activities (F = 8.02) was $7.77, $2.76, and $1.82, respectively. Similarly, with the inclusion 
of in-kind contributions, the average cost per case for core registry activities (F = 6.04) was 
$124.82, $70.09, and $36.03 for low-, medium-, and high-volume registries, respectively, 
while the distribution of enhanced activities (F = 5.06) was $9.75, $4.90, and $2.42, 
respectively.
Fig. 1 presents the cost per case for the 12 cancer registry activities with the highest costs, 
while Table 4 presents the average annual cost per case and differences across the registries 
by volume for the same activities. Overall, across all the 40 registries, the highest cost per 
case was incurred for data collection and abstraction ($8.33), management ($6.86), and 
administration ($4.99). Other activities – including analyzing and reporting, visual editing 
(viewing and correcting data manually), and database management – ranged from $2.40 to 
$3.40 per case reported. Across all the key activities, the cost per case for the high-volume 
registries was the lowest, followed by the medium-volume registries. The magnitude of the 
cost difference was largest for the top three activities based on cost per case: data collection 
and abstraction, management, and administration. For these activities, the difference 
between low- and high-volume registries ranged from $7.02 to $10.01 and, similarly, for 
medium- versus high-volume registries, the range was from $3.21 to $6.19. For all the 
top-12 activities, except IT support, the difference between low-volume and high-volume 
registries was much larger than that between medium- and high-volume registries.
4. Discussion
We reported on the differences in the cost incurred by NPCR-funded central cancer 
registries based on the volume of cancer registrations carried out by the registries. Based on 
analyses of 3 years of cost data from 40 registries, we identified large variations in the 
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average cost per case for core registration activities. Low-volume cancer registries incurred 
$93.11 on average (without in-kind contributions) to report a case compared with an average 
of $27.70 incurred by high-volume registries. In-kind contributions were received by all 
registries, with high-volume registries reporting the largest amounts and proportions 
compared to total funding. Despite these contributions, high-volume registries still had the 
lowest cost per case. Across all registries, more than 90% of the cost was allocated to core 
activities, and these patterns remained the same by volume across registries for core and 
enhanced activities, with high-volume registries incurring the lowest cost per case. Our 
results support previous studies that have reported significant economies of scale in cancer 
registries and programs (Weir et al., 2005; Tangka et al., 2010).
Across all registries, as expected, the highest cost was incurred for performing data 
collection and abstraction, with an average cost per case of $8.33. The next highest cost 
categories were management and administration, with cost per case of $6.86 and $4.99, 
respectively. All other activities had costs under $3.50 per case. Average cost estimates 
derived across all registries do not provide an accurate picture of the true cost of registration 
activities, as there are systematic differences due to the consistent relationship between cost 
per case and volume for all major activities performed by cancer registries. High-volume 
registries experience lower cost per case for data collection and abstraction, case 
ascertainment, visual editing, database management, and training of staff. Overall, low-
volume registries had consistently higher cost per case for all activities compared to 
medium-volume registries.
There are several differences in the characteristics of the registries by volume which can 
explain the large differences in cost reported for data collection and abstraction. Medium- 
and high-volume registries have a higher proportion of records submitted electronically, and 
high-volume registries also have larger proportions of cases passing 100% edits at the time 
of data submission (indicating that the initial submission to the registries is of high quality).
Overall, these differences indicate that high- and medium-volume registries are likely to 
receive better quality data than are low-volume registries, explaining to some extent the 
need for additional resources ($10.01 more for low- and $6.19 more for medium-volume 
registries, compared with high-volume registries) to review, re-abstract, and improve 
completeness and accuracy of the data. If the process of compiling a case is automated, as in 
medium- and high-volume registries, then any differences in the number of records may 
only have a negligible influence on resources required. One potential approach would be to 
examine whether efficiencies could be achieved in low-volume registry operations by 
increasing electronic submissions and implementing automated quality review processes.
Program management and administration activities also had substantial variation in cost per 
case, possibly because of the significant fixed costs associated with these activities. That is, 
regardless of the size of a registry, there are management and administrative activities that 
must take place to facilitate the cancer registration process. Collaborative registration 
activities or sharing resources among state programs, particularly for low-volume programs 
in nearby states, might help reduce some of these fixed costs. Lessons can be learned from 
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regional cancer registries that cover wide areas but collaborate to produce state-specific 
statistics.
Overall, there was a consistent pattern in the differences in the cost per case across all key 
registry activities. This indicates that there could be fixed costs associated with many of the 
registration processes. Additional research is required to accurately assess the proportion of 
fixed versus variable components of these activities. In this study, we used a top-down 
costing approach to assign activity-based costs; however, a bottom-up costing approach 
could be used in the future to identify the fixed, variable, and semi-variable nature of labor 
and non-labor resources required for key registration activities.
Adequate resources and efficient use of available funding are essential to ensuring high 
quality cancer registration data. There is some variation in the quality of the data reported by 
cancer registries, with high- and medium-volume registries more likely to receive NAACCR 
gold certification than low-volume registries (data presented in Table 1). Low-volume 
registries may fail to meet the highest levels of certification because of several reasons, 
including the quality of the data that is initially submitted to the registries, inefficiencies in 
the processes employed, and lack of resources needed to achieve high quality given the large 
fixed costs of cancer registration activities.
A potential limitation of the data analysis presented in this study is that the registries report 
data retrospectively, and the potential for error makes the reliability of retrospective data 
uncertain. However, registries were provided with detailed user’s guides and technical 
assistance to ensure that the highest quality data was compiled for this study. All sites made 
use of the user’s guide and attended training webinars; some sites were more intensive users 
of one-on-one technical support than others. A second limitation might be the geographic 
diversity of the registries. Even though the cost data were adjusted to control for regional 
variations in costs, we may not have been able to fully account for differences. Third, 
registration activities for a single cancer case can occur over several years. Although we 
used 3 years of data, there might have been a mismatch between registry cost and the 
reporting of cancer cases. Fourth, we only had a small number of registries in the high 
volume group compared to the other groups. Fifth, the staffing mix, in terms of seniority and 
training, can impact cost and data quality and we did not have detailed information to 
analyze this impact.
5. Lessons learned
The findings presented in this study provide a detailed assessment of the cost per case by 
volume of cancer registration to assist policy makers and cancer registry directors to 
improving operational efficiency. Comparing average cost of registry activities may distort 
the true cost of cancer registration, as low- and high-volume registries have differing cost 
structures. Some of these differences can be explained by the large fixed costs required for 
performing registration activities which include the overall data collection infrastructure and 
the management/administration oversight. Forming multi-state or regional partnerships can 
lead to lower cost per case as fixed cost of resources could be shared across multiple 
registries and economies of scale can be realized. Another reason might be the quality of the 
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data initially submitted to the registries. Automation or efficiency improvements could 
potentially reduce overall costs; for example, the use of electronic transmissions could 
significantly lower data collection and quality assessment costs. Additional research is 
needed to clarify the cost-benefit of implementing or expanding electronic data exchange as 
this will require some initial investment which will then result in data quality improvements 
and economic efficiency over time. Furthermore, micro-costing of time spent on specific 
high cost activities will provide valuable insights into the use of electronic systems and 
potentially task shifting to lower cost employees to increase cost-effectiveness of registry 
operations.
Appendix A
Table A1
Activity definitions used in the U.S. National Program of Cancer Registries—cost 
assessment tool.
Core activity definitions
1. Management: Addressing personnel and staffing issues; serving as liaison to other states and organizations; 
participating in NPCR, NAACCR, and NCRA committees; preparing registry applications and reports
2. Administration: Mailing, filing, logging, and other clerical tasks
3. Training of registry staff: Training of central registry staff; providing educational opportunities for staff, registry 
staff attending training-focused workshops such as NPCR Education and Training Coordinators, NAACCR, and NCRA; 
and leading meetings, webinars, conference calls, and other state and local training opportunities
4. Training of others by registry staff: Training CTRs as part of continuing education and other activities where 
registry staff trains those not working at the central registry. This includes answering QA questions and material 
development
5. Database management: Managing datasets for registry operations and special studies
6. IT support: Managing and supporting software updates, hardware upgrades, network maintenance, and creation of 
new systems and interfaces
7. Case ascertainment: Processing pathology reports, following up with physicians regarding pathology reports, and 
reviewing charts or reports
8. Death certificate clearance: Identifying incoming data sources, obtaining data from incoming sources, determining 
record and file structure, matching incoming records with cases in database, following up on cases requiring additional 
information, and determining statistical codes to update cases
9. Data collection/abstraction/data processing: Collecting, abstracting, and processing registry data from all health 
care providers
10. Analyzing data and generating reports: Performing descriptive and statistic data analysis and generating reports 
from the results
11. Sharing cases: Creating data-sharing agreements; facilitating or negotiating data-sharing agreements; creating, 
preparing, and submitting cases for data sharing; importing and editing incoming cases from data-sharing sources
12. Electronic case reporting and data encryption: Maintaining and increasing electronic case reporting from health 
care providers, including encrypting data
13. Call for data reporting requirements to CDC, NAACCR, and interstate data exchange: Preparing cases for 
required reporting years, preparing documentation required for reporting, reviewing cases from reporting agencies after 
data is submitted, and requesting resubmissions when required
14. Automatic case-finding and updating use of electronic links: Linking to electronic data sources and finding cases 
automatically through such linkages
15. Geocoding cancer cases: Attaching geographic identifier to the cancer registry data
16. QA: Visual editing: Manually evaluating the accuracy of a submitted case by comparing codes with supporting text 
or documents to find inconsistencies that may be missed by electronic edits, notifying reporters of errors, receiving 
corrections, and processing them
17. QA: Computer editing: Reviewing computer-generated edit reports for possible overrides or errors, notifying 
reporters, receiving corrections if needed, and processing final reports
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Core activity definitions
18. QA: Consolidating: Combining patient, tumor, and treatment information reported from multiple sources for each 
patient and tumor into one record that has complete and accurate information for the database
19. QA: Tracking dataflow: Monitoring the status of a case from its initial submission through the central registry 
processes until it is complete and added to the database
20. QA: Tracking completeness and timeliness: Determining the percentage of expected cases within a specific time 
period, calculating the reporting performance including completeness and submittal delay time, and notifying reporters 
of their status
21. QA: Auditing: Re-coding, re-abstracting, or reviewing case-ascertainment studies to assess the accuracy and 
completeness of facility reporting
22. Linking records to other state or national datasets: Creating and submitting data files to reporting agency as 
specified for matching and linking, incorporating linked records into each state’s data management system, procuring 
additional incoming data sources, importing cases from linked data sources, performing visual reviews, and updating 
cases from linked sources
Enhanced data and analysis activity definitions
23. Implementing a cancer inquiry response system: Answering requests for data and other cancer inquiry response 
system activities
24. Active follow-up: Performing active, rather than passive, follow-up as necessary
25. Research studies and other analysis using registry data: Investigating cancer clusters, performing special studies, 
and conducting other research and analysis using registry data
26. Publication of research studies using registry data: Preparing research studies resulting from registry data for 
publication
Abbreviations: CTR, Cancer Tumor Registrar; NAACCR, North American Association of Central Cancer Registries; 
NCRA, National Cancer Registrars Association; NPCR, National Program of Cancer Registries; QA, Quality Assurance.
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Fig. 1. 
Average cost per case for top 12 registry activities by volume of cases.
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Table 4
Difference in average cost per case for top 12 registry activities by volume of cases.
Activity Average all registries Difference—low vs high volume Difference—medium vs high 
volume
Data collection/abstraction $8.33 $10.01 $6.19
Management $6.86 $10.61 $4.11
Administration $4.99   $7.02 $3.21
Analyzing and generating reports $3.40   $3.82 $2.43
QA: Visual editing $3.19   $3.37 $2.40
Case ascertainment $3.13   $4.05 $2.37
QA: Consolidating $3.12   $2.82 $2.29
Database management $3.08   $4.36 $2.14
Training of registry staff $2.84   $3.75 $2.07
QA: Tracking completeness and timeliness $2.77   $3.90 $1.61
Death certificate clearance $2.48   $2.45 $2.17
IT support $2.43   $1.03 $2.21
Notes:
1
Low volume: fewer than 10,000 cases; medium volume: 10,000–50,000 cases; high volume: more than 50,000 cases.
2
Excludes Pacific Island Jurisdictions. Registry did not report cases diagnosed in 2006 and was still building capacity for case reporting.
3
Excludes NPCR registries that also receive SEER funding: California (San Francisco—Oakland, San Jose—Monterey, Los Angeles), Georgia 
(Atlanta), Kentucky, Louisiana, Michigan (Detroit), New Jersey, and Washington (Seattle-Puget Sound).
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